Digital Pathology News
TOKYO, (April 03, 2023)— Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive...
Andy Beck of PathAI: AI will continue to get better over time. Systems are continually improving and will be considerably more advanced looking ahead just five years from now. This expectation of progress gives us in the AI industry optimism...
Leica Biosystems: The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug...
PathAI: Part of Multi-year Partnership Focusing on Drug Development in NASH and Oncology BOSTON, March 30, 2023 /PRNewswire/ -- PathAI, a leading provider of AI-powered pathology, today announced its partnership with GSK...
PathologyWatch will use AWS Cloud solutions to advance technology capable of delivering digital pathology solutions on a global scale. SALT LAKE CITY (PRWEB) MARCH 27, 2023 - PathologyWatch today announced it has been selected to participate...
Samsung Medical Center has demonstrated the most comprehensive use of an integrated digital pathology to date. Given a rapidly aging population and an overwhelmed health system, hospitals like Samsung Medical Center had to deal with rising...
